Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors (Q45161618)

10 December 2017

title

Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors (English)

1 reference

10 December 2017

0 references

Barbara J Nicklas

1 reference

10 December 2017

Mary F Lyles

1 reference

10 December 2017

Tongjian You

1 reference

10 December 2017

Rongze Yang

series ordinal

1 reference

10 December 2017

Dawei Gong

series ordinal

1 reference

10 December 2017

publication date

23 November 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

10 December 2017

published in

1 reference

10 December 2017

volume

288

1 reference

10 December 2017

1 reference

10 December 2017

page(s)

E741-7

1 reference

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Leptin selectively decreases visceral adiposity and enhances insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Plasma leptin and insulin relationships in obese and nonobese humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Adiponectin gene expression and plasma values in obese women during very-low-calorie diet. Relationship with cardiovascular risk factors and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Plasma adiponectin levels and blood pressures in nondiabetic adolescent females

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Insulin action on expression of novel adipose genes in healthy and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Relationship between serum adiponectin and leptin concentrations and body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

A mathematical model for the determination of total area under glucose tolerance and other metabolic curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00419.2004

Effects of the menopause transition on body fatness and body fat distribution

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/J.1550-8528.1998.TB00344.X

Identifiers

DOI

10.1152/AJPENDO.00419.2004

1 reference

10 December 2017

1 reference